Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5189601
Max Phase: Preclinical
Molecular Formula: C22H20N4O
Molecular Weight: 356.43
Associated Items:
ID: ALA5189601
Max Phase: Preclinical
Molecular Formula: C22H20N4O
Molecular Weight: 356.43
Associated Items:
Canonical SMILES: Cc1nc2c(C(=O)Nc3ccccc3)cnn2c(C)c1Cc1ccccc1
Standard InChI: InChI=1S/C22H20N4O/c1-15-19(13-17-9-5-3-6-10-17)16(2)26-21(24-15)20(14-23-26)22(27)25-18-11-7-4-8-12-18/h3-12,14H,13H2,1-2H3,(H,25,27)
Standard InChI Key: ZCXHGNGTCRLAKB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 356.43 | Molecular Weight (Monoisotopic): 356.1637 | AlogP: 4.19 | #Rotatable Bonds: 4 |
Polar Surface Area: 59.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.51 | CX LogP: 4.17 | CX LogD: 4.17 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.60 | Np Likeness Score: -1.78 |
1. Zhang G, Wang F, Li S, Cheng KW, Zhu Y, Huo R, Abdukirim E, Kang G, Chou TF.. (2022) Discovery of small-molecule inhibitors of RUVBL1/2 ATPase., 62 [PMID:35364523] [10.1016/j.bmc.2022.116726] |
Source(1):